0001553846 1 2026-07-01 2026-07-01 0001553846 2026-07-01 2026-07-01 iso4217:USD pure shares F-3 EX-FILING FEES 0001553846 N/A N/A F-3 REDHILL BIOPHARMA LTD. false Equity Ordinary shares, par value NIS 0.01 per share true 262285730000 0.0001 26228573.00 0.0001381 3622.17 26228573.00 3622.17 0.00 0.00 3622.17 (1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the ordinary shares, par value NIS 0.01 per share (“Ordinary Shares”), and American Depositary Shares (“ADSs”) offered hereby also include an indeterminate number of additional Ordinary Shares and ADSs as may from time to time become issuable by reason of stock splits, stock dividends, recapitalizations or other transactions.<br/><br/>(2) American depositary shares evidenced by American depositary receipts issuable upon deposit of the Ordinary Shares registered hereby have been registered pursuant to a separate registration statement on Form F-6 (File No. 333-185302). Each ADS represents ten thousand (10,000) Ordinary Shares.<br/><br/>(3) Represents ordinary shares represented by ADSs registered for resale by the selling shareholders described herein.<br/><br/>(4) Estimated solely for the purpose of computing the amount of the registration fee for the ADSs being registered in accordance with Rule 457(c) under the Securities Act based upon the average of the high and low prices for an ADS of the registrant as reported on The Nasdaq Global Market on June 25, 2026, which date is within five business days of the filing of this registration statement.